ECTDP: Effects of Convective Therapies in Dialysis Patients

Sponsor
A. Manzoni Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01583309
Collaborator
(none)
146
27
3
51
5.4
0.1

Study Details

Study Description

Brief Summary

Convective therapies have been proposed for improving chronic dialysis patient outcomes, including intradialytic symptomatic hypotension.

To evaluate the frequency of sessions with intradialytic symptomatic hypotension in different types and doses of convective therapies compared with low-flux hemodialysis (HD), the investigators performed a multicentre, open-label, randomized controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Procedure: online pre-dilution hemofiltration
  • Procedure: online pre-dilution hemodiafiltration
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
146 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Convective Therapies in Dialysis Patients
Study Start Date :
Nov 1, 2003
Actual Primary Completion Date :
Feb 1, 2008
Actual Study Completion Date :
Feb 1, 2008

Arms and Interventions

Arm Intervention/Treatment
No Intervention: low-flux hemodialysis

Experimental: online pre-dilution hemofiltration

Procedure: online pre-dilution hemofiltration
Online pre-dilution hemofiltration was performed with a synthetic high-flux membrane and an infusate/blood flow ratio of one
Other Names:
  • online pre-dilution hemofiltration Technique
  • Experimental: online pre-dilution hemodiafiltration

    Procedure: online pre-dilution hemodiafiltration
    Online pre-dilution hemodiafiltration was performed with a synthetic high-flux membrane with an infusate/blood flow ratio of 0.6 and a dialysate plus infusate rate of 700 ml/min.
    Other Names:
  • online pre-dilution hemodiafiltration Technique
  • Outcome Measures

    Primary Outcome Measures

    1. Intradialytic symptomatic hypotension [all dialysis sessions, three per week, for 2 years]

      Intradialytic symptomatic hypotension was defined as a rapid symptomatic fall of the systolic blood pressure by at least 30 mmHg or that required nursing and/or medical intervention

    Secondary Outcome Measures

    1. Resistance to erythropoiesis-stimulating agents [Monthly for 2 years]

      Resistance to erythropoiesis-stimulating agents was measured as (EPO therapy in IU/week)/(Hb in g/dL*body wheight in kg)

    2. Calcium-phosphate metabolism [Monthly for 2 years]

      Outcome measures: phosphatemia, calcemia and PTH

    3. Beta2 microglobulin [Every six months for 2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Dialysis patients aged 18-80 years

    • thrice-weekly HD or HDF for at least 6 months

    • body weight less or equal to 90 Kg

    • stable clinical condition

    • written consent

    Exclusion Criteria:
    • infections

    • malignancies

    • active systemic diseases

    • active hepatitis or cirrhosis

    • unstable diabetes

    • diuresis higher than 200 ml/24h

    • dysfunction of vascular access

    • blood flow rate less than 300 ml/min

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ospedale S.Marta S.Venera Acireale (CT) Italy
    2 Ospedale F. Miulli Acquaviva delle Fonti Italy
    3 Ospedale Civile Alghero Italy
    4 Ospedale regionale di Aosta Aosta Italy
    5 Ospedale degli Infermi Biella Italy
    6 Ospedale SS. Trinità ASL 8 Cagliari Italy
    7 S. Michele Hospital Cagliari Italy
    8 Ospedale Civile "P. Merlo" La maddalena Italy
    9 Alessandro Manzoni Hospital Lecco Italy
    10 Ospedale "C. POMA" Mantova Italy
    11 T. EVOLI Melito Porto Salvo Italy
    12 Ospedale dell'Angelo Mestre Italy
    13 Policlinico Multimedica IRCCS Milano Italy
    14 Federico II Napoli Italy
    15 Ospedale San Francesco Nuoro Italy
    16 San Giovanni di Dio Olbia Italy
    17 Ospedale Antonio Segni Ozieri Italy
    18 Ospedale Maggiore Parma Italy
    19 Fondazione Maugeri Pavia Italy
    20 Ospedale " E. AGNELLI " Pinerolo Italy
    21 Dipartimento territoriale ASL 8 Quartu Sant'Elena Italy
    22 Ospedale S.Maria delle Croci Ravenna Italy
    23 Azienda Ospedaliera "Bianchi Melacrino Morelli," Reggio Calabria Italy
    24 Ospedale Bolognini Seriate Italy
    25 Ospedale Agostino Landolfi Solofra Italy
    26 Ospedale San Camillo Sorgono Italy
    27 ASL 2 Olbia - P.O. "P. Dettori", Tempio Pausania Italy

    Sponsors and Collaborators

    • A. Manzoni Hospital

    Investigators

    • Study Chair: Francesco Locatelli, Professor, A. Manzoni Hospital, Lecco - Italy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Prof. Francesco Locatelli, Professor Francesco Locatelli, A. Manzoni Hospital
    ClinicalTrials.gov Identifier:
    NCT01583309
    Other Study ID Numbers:
    • CONVESTUDY
    First Posted:
    Apr 24, 2012
    Last Update Posted:
    Apr 24, 2012
    Last Verified:
    Apr 1, 2012
    Keywords provided by Prof. Francesco Locatelli, Professor Francesco Locatelli, A. Manzoni Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 24, 2012